Although market SP is manipulated, IER will weigh in Sleepcheck FDA, Cough sound patent, and the data confirmation result. I will be surprised if the valuations are same as it was. However nobody, including Pfizer, want to waste a few more weeks to amend the already ASIC submitted scheme (Manipulation has a cost, and quarterly figure is coming). The exception is they have to based on IER revised value.
Although market SP is manipulated, IER will weigh in Sleepcheck...
-
- There are more pages in this discussion • 85 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)